Skip to main content
. 2019 Oct 16;9(25):7948–7960. doi: 10.7150/thno.39203

Figure 3.

Figure 3

(A) Biodistribution of 177Lu-EB-RGD in MC38 tumor bearing mice at 4, 24, 48 and 72 h post-injection (n = 4/group). (B) Biodistribution comparison of 177Lu-EB-RGD and 177Lu-RGD in MC38 tumor bearing mice at 4 h post-injection (n = 4/group).